Bioconstat
ActiveSummary
The computed 12-month bankruptcy probability of Bioconstat is 1.6% (moderate). The 2025 annual accounts show negative equity (-€125,415) and a net result of -€38,545. Equity is shrinking by about 34% per year across the filed financial years. Its solvency ranks better than 5% of 39,102 sector peers (NACE 70, financial year 2025). The company has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.